bpc-157 pharmacokinetics half-life study Frontiers BPC-157 and the Difference Between
Description
Friedman does not recommend GLP-1s in patients with low muscle mass to begin with
[DOI] [PMC free article] [PubMed] [Google Scholar] 95.Skorjanec S., Kokot A., Drmic D., Radic B., Sever M., Klicek R., Kolenc D., Zenko A., Lovric Bencic M., Belosic Halle Z., et al
2012;7:e42357
We will ensure allocation concealment throughout the study as none of the investigators will have access to this list until completion of data collection
